Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial.
Rasoul S, Ottervanger JP, de Boer MJ, Miedema K, Hoorntje JC, Gosselink M, Zijlstra F, Suryapranata H, Dambrink JH, van 't Hof AW. Rasoul S, et al. Among authors: dambrink jh. Eur Heart J. 2006 Jun;27(12):1401-7. doi: 10.1093/eurheartj/ehl004. Epub 2006 May 8. Eur Heart J. 2006. PMID: 16682384 Clinical Trial.
Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison.
Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Suryapranata H, Hoorntje JC, Gosselink AT, van 't Hof AW; ELISA study group. Rasoul S, et al. Among authors: dambrink jh. J Thromb Thrombolysis. 2007 Dec;24(3):241-6. doi: 10.1007/s11239-007-0015-y. Epub 2007 Mar 2. J Thromb Thrombolysis. 2007. PMID: 17334935 Clinical Trial.
Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial.
Timmer JR, ten Berg J, Heestermans AA, Dill T, van Werkum JW, Dambrink JH, Suryapranata H, Ottervanger JP, Hamm C, van 't Hof AW; Ongoing Tirofiban In Myocardial Infarction Evaluation (On - Time) 2 study group. Timmer JR, et al. Among authors: dambrink jh. EuroIntervention. 2010 Aug;6(3):336-42. doi: 10.4244/EIJV6I3A56. EuroIntervention. 2010. PMID: 20884411 Clinical Trial.
Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age.
Otten AM, Maas AH, Ottervanger JP, Kloosterman A, van 't Hof AW, Dambrink JH, Gosselink AT, Hoorntje JC, Suryapranata H, de Boer MJ; Zwolle Myocardial Infarction study Group. Otten AM, et al. Among authors: dambrink jh. Eur Heart J Acute Cardiovasc Care. 2013 Dec;2(4):334-41. doi: 10.1177/2048872612475270. Epub 2013 Jan 31. Eur Heart J Acute Cardiovasc Care. 2013. PMID: 24338292 Free PMC article.
Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.
Hoedemaker NPG, Damman P, Ottervanger JP, Dambrink JHE, Gosselink ATM, Kedhi E, Kolkman E, de Winter RJ, van 't Hof AWJ. Hoedemaker NPG, et al. Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):127-138. doi: 10.1093/ehjcvp/pvy030. Eur Heart J Cardiovasc Pharmacother. 2019. PMID: 30084902
Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction.
Zijlstra F, Ernst N, de Boer MJ, Nibbering E, Suryapranata H, Hoorntje JC, Dambrink JH, van 't Hof AW, Verheugt FW. Zijlstra F, et al. Among authors: dambrink jh. J Am Coll Cardiol. 2002 Jun 5;39(11):1733-7. doi: 10.1016/s0735-1097(02)01856-9. J Am Coll Cardiol. 2002. PMID: 12039484 Free article.
191 results